跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VALPROATO SODICO AUROVITAS 200 MG/ML SOLUCION ORAL EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VALPROATO SODICO AUROVITAS 200 MG/ML SOLUCION ORAL EFG
Approved
STANDARD
VALPROATO SODICO AUROVITAS 200 MG/ML SOLUCION ORAL EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 25, 2020
Approval ID
26105218f21db616
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
26105218f21db616
Drug Cima Aemps Name
VALPROATO SODICO AUROVITAS 200 MG/ML SOLUCION ORAL EFG
Register Number
85097
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2020-05-25
Dosage Form
SOLUCIÓN ORAL
Dose
200 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
No
Company Name
Aurovitas Spain, S.A.U.
Active Ingredients
VALPROATO SODIO
200 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 25, 2020
Approval ID
26105218f21db616
Type
Standard
Back to CIMA-AEMPS Approvals